Business Context and Reporting Period
Aimei Health Technology Co., Ltd. (AFJK) is a Cayman Islands exempted company and a blank check entity (SPAC) formed on April 27, 2023. The company intends to pursue a business combination with targets in the healthcare innovation sector, specifically biopharmaceuticals, medical technology, and diagnostics. As of June 30, 2024, the company had not commenced operations; its activities were limited to formation, its Initial Public Offering (IPO) consummated in December 2023, and the evaluation of business combination candidates.
Reporting Period: Quarterly period ended June 30, 2024.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2024 | Three Months Ended June 30, 2024 |
|---|---|---|
| Revenue | $0 (No operating revenue) | $0 |
| Net Income | $1,364,592 | $609,092 |
| Operating Costs | $(462,746) | $(309,114) |
| Interest Income (Trust Account) | $1,827,338 | $918,206 |
| Cash (Operating) | $157,505 | N/A |
| Trust Account Balance | $71,717,186 | N/A |
| Total Assets | $71,921,531 | N/A |
| Total Liabilities | $801,215 | N/A |
| Working Capital | $93,130 | N/A |
| Debt | $0 (No outstanding working capital loans) | N/A |
Material Changes vs. Prior Period
- Profitability: The company reported a net income of $1,364,592 for the six months ended June 30, 2024, compared to a net loss of $3,618 for the period from inception (April 27, 2023) through June 30, 2023. This shift is driven entirely by interest income earned on the Trust Account, which was non-existent in the prior period.
- Trust Account Growth: The Trust Account balance increased from $69,889,848 as of December 31, 2023, to $71,717,186 as of June 30, 2024, due to accrued interest.
- Operating Cash Flow: Net cash used in operating activities was $423,212 for the six months ended June 30, 2024, compared to zero for the prior period, reflecting increased operational expenditures.
- Liabilities: Current liabilities increased to $111,215 from $24,841 at year-end 2023, primarily due to accrued expenses and amounts due to a related party.
Outlook, Risks, and Unusual Items
Business Combination Agreement
On June 19, 2024, the company entered into a definitive Business Combination Agreement with United Hydrogen Group Inc. The transaction involves a merger structure where the Company will become a wholly-owned subsidiary of the surviving entity. The agreement includes a termination date of March 31, 2025, if conditions are not satisfied.
Liquidity and Going Concern
Management has determined that the requirement to cease operations and liquidate if a business combination is not consummated within the prescribed period raises substantial doubt about the company's ability to continue as a going concern. The financial statements do not include adjustments that might result from this uncertainty.
Controls and Procedures
Management concluded that as of June 30, 2024, the company's disclosure controls and procedures were not effective.
Related Party Transactions
The company owes $51,803 to a related party for administrative and offering costs. The Sponsor has agreed to pay $10,000 per month for administrative services; $60,000 was unpaid as of June 30, 2024.
Investor Verification Checklist
- Merger Status: Verify the current status of the proposed business combination with United Hydrogen Group Inc. and any shareholder approval requirements.
- Redemption Rights: Confirm the redemption price per share (currently approx. $10.39) and the potential impact of shareholder redemptions on the Trust Account balance.
- Going Concern: Assess the risk of liquidation if the merger fails to close by the deadline (potentially extendable to 24 months from IPO).
- Internal Controls: Review the specific deficiencies cited regarding the ineffectiveness of disclosure controls and procedures.
- Deferred Fees: Note the $690,000 deferred underwriting commission payable only upon successful closing of the business combination.